**Abbreviations:**

BMMSCs, bone marrow mesenchymal stem cells; ESCs, embryonic stem cells

INTRODUCTION {#sec1-1}
============

Spinal cord injury is a serious trauma to the central nervous system, which presents with high incidence, disability and cost. It is a serious hazard to human health, and places a heavy burden on patients and their families. Spinal cord injury causes the loss of numerous spinal neurons, and there is a lack of neurogenesis to promote spinal repair. Maintaining cell survival, regenerating axons, positioning regenerated axons, and rebuilding synapses are the main difficulties for functional recovery after spinal injury\[[@ref1]\]. Although various methods including surgery, medication and physical rehabilitation are performed for the treatment of spinal injury, there is not an ideal effective method to cure spinal injury. Tissue-engineered cell transplantation provides a new approach for treating spinal cord injury, which may repair or regenerate injured axons and recover partial spinal functions. Currently, bone marrow mesenchymal stem cells (BMMSCs), embryonic stem cells (ESCs), and umbilical cord blood stem cells are used for treating spinal cord injury. BMMSCs have a good differentiation capacity, and transplanted BMMSCs can partially repair neural functions\[[@ref2]\]. Brazelton *et al*\[[@ref3]\] found that exogenous BMMSCs differentiate into glial cells and neurons after transplantation into mouse brain, suggesting that BMMSC transplantation can be used for treating spinal cord injury. Sasaki *et al*\[[@ref4]\] used BMMSC transplantation to treat spinal cord injury and found that BMMSCs can repair the myelin sheath of damaged spinal axons. Neural stem cells show special features due to isogenesis with cells in spinal areas\[[@ref5]\]. Thus, BMMSC transplantation has been the study focus of an increasing number of researchers\[[@ref6][@ref7]\]. Additionally, gene-modified neural stem cells have been applied in clinical studies that mainly focus on providing a suitable microenvironment for stem cells in damaged spinal cord\[[@ref8][@ref9]\]. The mechanisms of cell transplantation, which promote neural regeneration in damaged spinal function include: (1) Providing necessary conditions for neuronal and axonal regeneration; (2) To substitute or generate new neurons to form new synapses; and (3) To guide axons for alignment in order in tissue- engineered scaffolds to form new synapses. In damaged spinal cord, interneurons derived from stem cells provide a bridge to possibly reconnect the damaged spinal cord and recover spinal functions\[[@ref10][@ref11][@ref12][@ref13]\]. Zuk *et al*\[[@ref14]\] isolated adipose-derived mesenchymal stem cells and found that they can be induced to differentiate into neuron-like cells. Furthermore, Safford *et al*\[[@ref15]\] found that adipose-derived mesenchymal stem cells can be induced to differentiate into neurons and cells from other tissues.

DATA SOURCES AND METHODOLOGY {#sec1-2}
============================

Data retrieval {#sec2-1}
--------------

In this study, we used bibliometric analyses to quantitatively and qualitatively investigate research trends in studies of stem cell transplantation for treating spinal cord injury. For this purpose, we employed the Web of Science, a research database of publications and citations that are selected and evaluated by the Institute for Scientific Information in Philadelphia, PA, USA, using the key words "bone marrow mesenchymal stem cells" "embryonic stem cells" "umbilical cord blood derived mesenchymal stem cells" "adipose derived mesenchymal stem cells" "cell transplantation" and "spinal cord injury". We limited the period of publication from 2002 to 2011 to compile a bibliography of all articles related to stem cell transplantation for treating spinal cord injury. We downloaded the data on March 25, 2012.

Inclusion criteria {#sec2-2}
------------------

The inclusion criteria were as follows: (1) Peer-reviewed articles on stem cell transplantation for treating spinal cord injury, which were published and indexed in the Web of Science, including original research articles, reviews, meeting abstracts, proceedings papers, book chapters, editorial material, and news items; (2) the year of publication was 2002-2011; and (3) the citation database was Science Citation Index-Expanded.

Exclusion criteria {#sec2-3}
------------------

We excluded articles that required manual searching or telephone access, documents that were not published in the public domain, and a number of corrected papers from the total number of articles analyzed.

The outcomes of all articles referring to stem cell transplantation for treating spinal cord injury were measured using the following criteria. (a) Annual publication output on stem cell transplantation for treating spinal cord injury, included in the Web of Science from 2002 to 2011; (b) publications on stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011 according to country. (c) publications on stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011, by institution; (d) distribution of publications on stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011 by funding agencies; and (e) the most cited papers on stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011.

RESULTS {#sec1-3}
=======

Search results of publications addressing stem cells obtained from different sources for treating spinal cord injury from 2002 to 2011 ([Table 1](#T1){ref-type="table"}) {#sec2-4}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Number of publications addressing stem cells obtained from different sources for treating spinal cord injury included in the Web of Science from 2002 to 2011

![](NRR-7-1256-g001)

Annual publication output of BMMSC transplantation for treating spinal cord injury from 2002 to 2011 ([Figure 1](#F1){ref-type="fig"}) {#sec2-5}
--------------------------------------------------------------------------------------------------------------------------------------

![Annual number of publications on bone marrow mesenchymal stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011.](NRR-7-1256-g002){#F1}

There were 191 publications on BMMSC transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011. The number of publications on BMMSC transplantation for treating spinal cord injury has gradually increased over the past 10 years. In total, no papers were published and included in the Web of Science in 2002, but the number of published papers increased to 33 in 2011. However, there was a slight decrease in the number of papers published in 2005 and 2007.

Publication distribution of countries and institutes based on BMMSC transplantation for treating spinal cord injury from 2002 to 2011 ([Table 2](#T2){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}) {#sec2-6}
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

The top 10 countries on bone marrow mesenchymal stem cell transplantation for treating spinal cord injury from 2002 to 2011

![](NRR-7-1256-g003)

![The top 10 institutes for publications on BMMSC transplantation for treating spinal cord injury from 2002 to 2011.\
I: Hokkaido University; II: Sun Yat-sen University; III: Autonomous University of Madrid; IV: Chiba University; V: China Medical University; VI: Hiroshima University; VII: Kyoto University; VIII: Radboud University Nijmegen; IX: Aino University; X: Chonbuk National University.](NRR-7-1256-g004){#F2}

The contribution analysis of different countries/territories for publications was based on journal articles in which the address and affiliation of at least one author were provided. The total number of articles analyzed by country and institute publications was 191.

From [Table 2](#T2){ref-type="table"}, it is clear that Japan published the most papers on BMMSC transplantation for treating spinal cord injury. Japan published 34 papers that accounted for 25.75% of the total, which was much higher than the number of publications by other countries. China ranked second with 33 papers that accounted for 25%. The USA published 27 papers and ranked third.

Hokkaido University, Sun Yat-sen University and the Autonomous University of Madrid were the most prolific research institutes for publications on BMMSC transplantation for treating spinal cord injury. Among the top 10 research institutes publishing in this field, four are in Japan, two are in China, two are in South Korea, and there is one institute each in Spain and the Netherlands.

Most cited articles on BMMSC transplantation for treating spinal cord injury from 2002 to 2011 ([Table 3](#T3){ref-type="table"}) {#sec2-7}
---------------------------------------------------------------------------------------------------------------------------------

###### 

Articles with more than 60 total citations on bone marrow mesenchymal stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011

![](NRR-7-1256-g005)

Among the seven articles with more than 60 citations, the article "bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation", published in 2004, was cited 117 times, which was more times than any other article.

Most funding support for BMMSC transplantation for treating spinal cord injury from 2002 to 2011 ([Table 4](#T4){ref-type="table"}) {#sec2-8}
-----------------------------------------------------------------------------------------------------------------------------------

###### 

Funding agencies on bone marrow mesenchymal stem cell transplantation for treating spinal cord injury from 2002 to 2011

![](NRR-7-1256-g006)

Among the publications, 12 articles were supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and eight articles were supported by the National Natural Science Foundation of China.

Journals that published on BMMSC transplantation for treating spinal cord injury from 2002 to 2011 ([Table 5](#T5){ref-type="table"}) {#sec2-9}
-------------------------------------------------------------------------------------------------------------------------------------

###### 

Top 14 journals that published studies of bone marrow mesenchymal stem cell transplantation for treating spinal cord injury from 2002 to 2011

![](NRR-7-1256-g007)

In [Table 5](#T5){ref-type="table"}, it is evident that most papers on BMMSC transplantation for treating spinal cord injury appeared in journals with a particular focus on neuroscience research. Cell Transplantation published 11 papers that accounted for 5.76% of the total number of publications, which was followed by the *Journal of Neurotrauma* that published 10 papers and accounted for 5.24%.

Annual publication output for ESC transplantation for treating spinal cord injury from 2002 to 2011 ([Figure 3](#F3){ref-type="fig"}) {#sec2-10}
-------------------------------------------------------------------------------------------------------------------------------------

![Annual number of publications on embryonic stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011.](NRR-7-1256-g008){#F3}

There were 236 publications on ESC transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011. The number of publications on ESC transplantation for treating spinal cord injury has gradually increased over the past 10 years. In total, 47 papers were published and included in the Web of Science in 2011, which had increased by more than 20 times than that in 2002.

Publication distribution of countries and institutes based on ESC transplantation for treating spinal cord injury from 2002 to 2011 ([Table 6](#T6){ref-type="table"} and [Figure 4](#F4){ref-type="fig"}) {#sec2-11}
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

The top 10 countries on embryonic stem cell transplantation for treating spinal cord injury from 2002 to 2011

![](NRR-7-1256-g009)

![The top 10 institutes publishing on embryonic stem cell transplantation for treating spinal cord injury from 2002 to 2011.\
I: Washington University; II: University of California, Irvine; III: Keio University; IV: Harvard University; V: Geron Corporation; VI: Karolinska Institutet; VII: Stanford University; VIII: University of Cambridge; IX: University of Hamburg; X: University of Toronto.](NRR-7-1256-g010){#F4}

The contribution analysis of different countries/territories for publications was based on journal articles in which the address and affiliation of at least one author were provided. The total number of articles analyzed for country and institute publications was 191. The top 10 countries/territories and institutions were then ranked.

In [Table 6](#T6){ref-type="table"}, it is clear that the USA published the most papers on ESC transplantation for treating spinal cord injury, with 110 papers that accounted for 46.61% of the total, which was much higher than the number of papers published by other countries. Japan ranked second with 21 papers that accounted for 8.89%. Germany published 19 papers and ranked third.

Washington University, University of California, Irvine, and Keio University are the most prolific research institutes publishing on ESC transplantation for treating spinal cord injury. Among the top 10 research institutes publishing in this field, five are in the USA, and the other five are in Japan, Sweden, the UK, Germany and Canada.

Most funding support for ESC transplantation for treating spinal cord injury from 2002 to 2011 ([Table 7](#T7){ref-type="table"}) {#sec2-12}
---------------------------------------------------------------------------------------------------------------------------------

###### 

Funding support on embryonic stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011

![](NRR-7-1256-g011)

Among the publications, 13 articles were supported by the NIH, and three articles were supported by CONACYT and the National Institutes of Health. The other funding agencies supported less than 2 publications.

Most cited articles on ESC transplantation for treating spinal cord injury from 2002 to 2011 ([Table 8](#T8){ref-type="table"}) {#sec2-13}
-------------------------------------------------------------------------------------------------------------------------------

###### 

Articles with more than 70 total citations on embryonic stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011

![](NRR-7-1256-g012)

Among the 10 articles with more than 70 citations, the article "Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury", published in 2005, was cited 394 times, which was greater than any other article.

Journals that published on ESC transplantation for treating spinal cord injury from 2002 to 2011 ([Table 9](#T9){ref-type="table"}) {#sec2-14}
-----------------------------------------------------------------------------------------------------------------------------------

###### 

Top 17 journals that published studies of embryonic stem cell transplantation for treating spinal cord injury from 2002 to 2011

![](NRR-7-1256-g013)

In [Table 9](#T9){ref-type="table"}, it is evident that most papers on ESC transplantation for treating spinal cord injury appeared in journals such as *Stem Cells, Cell Transplantation* and *PLoS One*.

Highly cited papers on other sources of stem cells for transplantation to treat spinal cord injury (Tables [10](#T10){ref-type="table"} and [11](#T11){ref-type="table"}) {#sec2-15}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Top eight articles on umbilical cord blood stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011

![](NRR-7-1256-g014)

###### 

Top four articles on adipose derived stem cell transplantation for treating spinal cord injury in the Web of Science from 2002 to 2011

![](NRR-7-1256-g015)

DISCUSSION {#sec1-4}
==========

Based on our bibliometric analysis of the Web of Science, we found the following research trends for studies of stem cell transplantation for treating spinal cord injury over the past 10 years.

BMMSCs and ESCs are widely used for treating spinal cord injury, with 191 studies of BMMSC transplantation and 236 studies of ESC transplantation for treating spinal cord injury appearing in the Web of Science from 2002 to 2011, and almost half of which are from American or Japanese authors and institutes. Although umbilical cord blood stem cells and adipose-derived stem cells have been studied for treating spinal cord injury, the published papers are much fewer, with only 21 and 17 records, respectively, which are included in the Web of Science.

The number of studies of stem cell transplantation for treating spinal cord injury has gradually increased over the past 10 years. Most papers on stem cell transplantation for treating spinal cord injury are in journals with a particular focus on stem cell research, such as *Stem Cells* and *Cell Transplantation*.

Much attention and effort has been devoted to spinal cord injury treatment using stem cell transplantation. The findings of the present study may be of interest to fellow researchers who are currently undertaking studies of stem cell transplantation for treating spinal cord injury or those who may do so in the future.
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